| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Articles: Hormones and Reproductive Health |
Division of Reproductive Sciences (O.D.S., N.R.N., R.M.B.), Oregon Regional Primate Research Center, Beaverton, Oregon 97006; Center for Reproductive Biology (K.A.B., S.T.C., H.O.D.C., D.T.B.), University of Edinburgh, EH3 9ET Edinburgh, United Kingdom; and Schering AG (K.C.), D13342 Berlin, Germany
Address correspondence and requests for reprints to: Robert M. Brenner, Ph.D., Oregon Regional Primate Research Center, 505 N.W. 185th Avenue, Beaverton, Oregon 97006.
Abstract
Antiprogestins (APs) inhibit estradiol (E2)-stimulated endometrial growth in women and nonhuman primates, but the mechanism of this "antiestrogenic" action is unknown. Here, we report that APs up-regulate endometrial androgen receptor (AR) in both women and macaques, an effect that might play a role in the antiproliferative effects of APs on the primate endometrium. In addition, because there are discrepancies in the literature on the regulation and localization of AR in the primate endometrium, we used both in situ hybridization and immunocytochemistry to evaluate hormonal influences on endometrial AR in women and macaques. In ovariectomized macaques, the following treatments were given for 4 weeks each: E2 alone, E2 + progesterone (P), E2 + mifepristone (RU 486), and E2 + P + RU 486. In women, samples were obtained during the normal menstrual cycle and after treatment with either RU 486 for 30 days at 2 mg/day, or after a single oral administration of 200 mg RU 486 on cycle day LH + 2. In macaques, E2 significantly increased AR expression above vehicle controls; E2 + RU 486 increased binding further; E2 + P decreased AR binding; and E2 + P + RU 486 treatment caused an intermediate elevation in AR binding. In macaques treated with E2 alone, stromal AR staining was predominant, and P treatment suppressed that staining. E2 + RU 486 or E2 + P + RU 486 treatment produced a striking up-regulation of glandular epithelial AR staining and enhanced the stromal AR signal. In situ hybridization analyses confirmed the immunocytochemistry data. Similar induction of glandular AR staining and enhanced stromal AR staining were obtained in macaques treated with ZK 137 316 and ZK 230 211. During the natural cycle in women, stromal AR staining predominated and was greater in the proliferative than the late secretory phase. RU 486 treatment of women up-regulated glandular epithelial AR staining after either daily treatment for 30 days with 2 mg/day or after a single oral dose of 200 mg. In summary, endometrial AR was highest in the stroma during the human proliferative phase (or during E2 treatment in macaques) and lowest during the late secretory phase in women (or after E2 + P treatment in macaques). In both species, RU 486 induced AR expression in the glands and enhanced AR expression in stromal cells. Because androgens can antagonize E2 action, enhanced endometrial AR expression induced by APs could play a role in the antiproliferative, "antiestrogenic" effects of APs in primates.
This article has been cited by other articles:
![]() |
H. O. D. Critchley and P. T. K. Saunders Hormone Receptor Dynamics in a Receptive Human Endometrium Reproductive Sciences, February 1, 2009; 16(2): 191 - 199. [Abstract] [PDF] |
||||
![]() |
R. A. Fochi, A. P.S. Perez, C. V. Bianchi, S. S. Rochel, R. M. Goes, P. S.L. Vilamaior, S. R. Taboga, and F. C.A. Santos Hormonal Oscillations During the Estrous Cycle Influence the Morphophysiology of the Gerbil (Meriones unguiculatus) Female Prostate (Skene Paraurethral Glands) Biol Reprod, December 1, 2008; 79(6): 1084 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. de Giorgio-Miller, P. Bungay, M. Tutt, J. Owen, D. Goodwin, and N. Pullen The Translational Pharmacology of a Novel, Potent, and Selective Nonsteroidal Progesterone Receptor Antagonist, 2-[4-(4-Cyano-phenoxy)-3,5-dicyclopropyl-1H-pyrazol-1-yl]-N-methylacetamide (PF-02367982) J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 78 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Cloke, K. Huhtinen, L. Fusi, T. Kajihara, M. Yliheikkila, K.-K. Ho, G. Teklenburg, S. Lavery, M. C. Jones, G. Trew, et al. The Androgen and Progesterone Receptors Regulate Distinct Gene Networks and Cellular Functions in Decidualizing Endometrium Endocrinology, September 1, 2008; 149(9): 4462 - 4474. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Engman, L. Skoog, G. Soderqvist, and K. Gemzell-Danielsson The effect of mifepristone on breast cell proliferation in premenopausal women evaluated through fine needle aspiration cytology Hum. Reprod., September 1, 2008; 23(9): 2072 - 2079. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hayashi, A. R O'Connell, J. L Juengel, K. P McNatty, G. H Davis, F. W Bazer, and T. E Spencer Postnatal uterine development in Inverdale ewe lambs Reproduction, March 1, 2008; 135(3): 357 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bai, G. Grossman, L. Yuan, B. A. Lessey, F. S. French, S. L. Young, and E. M. Wilson Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantation Mol. Hum. Reprod., February 1, 2008; 14(2): 107 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vani, S. E. McDonald, A. R.W. Williams, J. I. Mason, K. J. Thong, and H. O.D. Critchley Mid-luteal endometrial intracrinology following controlled ovarian hyperstimulation involving use of a gonadotrophin releasing hormone antagonist Hum. Reprod., November 1, 2007; 22(11): 2981 - 2991. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishikawa, T. Harada, T. Kubota, and T. Aso Testosterone inhibits matrix metalloproteinase-1 production in human endometrial stromal cells in vitro Reproduction, June 1, 2007; 133(6): 1233 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
O.D. Slayden, M.B. Zelinski, K. Chwalisz, H. Hess-Stumpp, and R.M. Brenner Chronic progesterone antagonist-estradiol therapy suppresses breakthrough bleeding and endometrial proliferation in a menopausal macaque model Hum. Reprod., December 1, 2006; 21(12): 3081 - 3090. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Jabbour, R. W. Kelly, H. M. Fraser, and H. O. D. Critchley Endocrine Regulation of Menstruation Endocr. Rev., February 1, 2006; 27(1): 17 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Milne, T. A. Henderson, R. W. Kelly, P. T. Saunders, D. T. Baird, and H. O. D. Critchley Leukocyte Populations and Steroid Receptor Expression in Human First-Trimester Decidua; Regulation by Antiprogestin and Prostaglandin E Analog J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4315 - 4321. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Pocar, B Fischer, T Klonisch, and S Hombach-Klonisch Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction Reproduction, April 1, 2005; 129(4): 379 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gemzell-Danielsson and L. Marions Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception Hum. Reprod. Update, July 1, 2004; 10(4): 341 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Narvekar, S. Cameron, H. O. D. Critchley, S. Lin, L. Cheng, and D. T. Baird Low-Dose Mifepristone Inhibits Endometrial Proliferation and Up-Regulates Androgen Receptor J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2491 - 2497. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vienonen, S. Miettinen, M. Blauer, P. M. Martikainen, E. Tomas, P. K. Heinonen, and T. Ylikomi Expression of Nuclear Receptors and Cofacotrs in Human Endometrium and Myometrium Reproductive Sciences, February 1, 2004; 11(2): 104 - 112. [Abstract] [PDF] |
||||
![]() |
K. A. Burton, T. A. Henderson, S. G. Hillier, J.I. Mason, F. Habib, R. M. Brenner, and H. O.D. Critchley Local levonorgestrel regulation of androgen receptor and 17{beta}-hydroxysteroid dehydrogenase type 2 expression in human endometrium Hum. Reprod., December 1, 2003; 18(12): 2610 - 2617. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.T. Baird, A. Brown, H.O.D. Critchley, A.R. Williams, S. Lin, and L. Cheng Effect of long-term treatment with low-dose mifepristone on the endometrium Hum. Reprod., January 1, 2003; 18(1): 61 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.M. Borman, K.M. Schwinof, C. Niemeyer, K. Chwalisz, R.L. Stouffer, and M.B. Zelinski-Wooten Low-dose antiprogestin treatment prevents pregnancy in rhesus monkeys and is reversible after 1 year of treatment Hum. Reprod., January 1, 2003; 18(1): 69 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chegini, C. Ma, X.M. Tang, and R.S. Williams Effects of GnRH analogues, `add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-{beta} expression Mol. Hum. Reprod., December 1, 2002; 8(12): 1071 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Hapangama, H. O. D. Critchley, T. A. Henderson, and D. T. Baird Mifepristone-Induced Vaginal Bleeding Is Associated with Increased Immunostaining for Cyclooxygenase-2 and Decrease in Prostaglandin Dehydrogenase in Luteal Phase Endometrium J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5229 - 5234. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. O. D. Critchley, T. A. Henderson, R. W. Kelly, G. S. Scobie, L. R. Evans, N. P. Groome, and P. T. K. Saunders Wild-Type Estrogen Receptor (ER{beta}1) and the Splice Variant (ER{beta}cx/{beta}2) Are Both Expressed within the Human Endometrium throughout the Normal Menstrual Cycle J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5265 - 5273. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Gregory, E. M. Wilson, K. B. C. Apparao, R. A. Lininger, W. R. Meyer, A. Kowalik, M. A. Fritz, and B. A. Lessey Steroid Receptor Coactivator Expression throughout the Menstrual Cycle in Normal and Abnormal Endometrium J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2960 - 2966. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Nayak and R. M. Brenner Vascular Proliferation and Vascular Endothelial Growth Factor Expression in the Rhesus Macaque Endometrium J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1845 - 1855. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.B.C. Apparao, L. P. Lovely, Y. Gui, R. A. Lininger, and B. A. Lessey Elevated Endometrial Androgen Receptor Expression in Women with Polycystic Ovarian Syndrome Biol Reprod, February 1, 2002; 66(2): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |